Skip to main content

Articles

Intravenous Iron Better Tolerated Than Oral Iron for Chemotherapy-Induced Anemia
Gunnar Birgegård, MD, PhD, discussed his team’s research comparing intravenous iron isomaltoside 1000 with oral iron sulphate monotherapy in patients with cancer and chemotherapy-induced anemia at the 2015 International Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology Symposium on Supportive Care in Cancer.
Read More ›

The National Prescription Drug Take-Back addresses a vital public safety and public health issue. Many patients are not aware that the medicines in their cabinets are highly susceptible to diversion, misuse, and abuse.
Read More ›

Adherence to certain strategies can aid pharmacists in successful navigation of our increasingly collaborative healthcare landscape.
Read More ›

Managing Dermatologic Toxicities
At the National Comprehensive Cancer Network 20th Annual Conference, Mario E. Lacouture, MD, presented some clinical pearls that can guide the management of dermatologic toxicities.
Read More ›

Developing a Pharmacist-Driven Drug-Monitoring Protocol
Felicia Zook, PharmD, BCOP, discussed her medical practice’s successful development and implementation of a pharmacist-driven drug-monitoring protocol at the 11th annual Hematology/Oncology Pharmacy Association conference.
Read More ›

Meeting USP Chapter 800 Head On
Michael Koraleski, PharmD, outlined the proposed standards of the newest US Pharmacopeial Convention (USP) Chapter 800 at the 11th annual Hematology/Oncology Pharmacy As­­sociation conference.
Read More ›

Immune Checkpoint Blockade Shows Durable Responses in Lung and Kidney Cancers, Metastatic Melanoma
The National Com­prehensive Cancer Network (NCCN) now recommends nivolumab (Opdivo) as subsequent therapy for metastatic squamous non–small-cell lung cancer (NSCLC) after its recent FDA approval.
Read More ›

Although recent studies have shown the efficacy of using ster­eotactic body radiation therapy (SBRT) as a treatment modality for organ-confined prostate cancer, questions over urinary symptoms and sexual dysfunction have remained.
Read More ›

  • Abiraterone and Metabolic Syndrome
  • Obesity and Survival in Metastatic Renal-Cell Carcinoma
  • Radium-223 and Pain
  • New Biomarker for Survival
  • Quality of Life in Long-Term Survivors of Bladder Cancer
Read More ›

A successful pharmacist-­driven drug-monitoring protocol can be achieved in a medical practice when necessary elements are considered.
Read More ›

Page 137 of 289